BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  GenMark Diagnostics to Participate in the J.P. Morgan Healthcare Conference

  GenMark Diagnostics, Inc. announced that the company plans to participate in the upcoming J.P. Morgan Healthcare conference in San Francisco, California..

  December 30, 2019

   · 

  1 min read
• Job Trends

  XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen

  Validation and Capital from Deal Enables XBiotech to Vigorously Advance anti-IL-1⍺ Antibody Program, Fuel Pipeline

  December 30, 2019

   · 

  5 min read
• BioMidwest

  Hillrom to Present at the 38th Annual J.P. Morgan Healthcare Conference

  Hillrom, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020, in San Francisco. John Groetelaars, Hillrom’s president and chief executive officer, is scheduled to present at 4:30 p.m. Pacific Time.

  December 30, 2019

   · 

  1 min read
• Deals

  Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.

  The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the completion of the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees, from XBiotech Inc., for $750 million.

  December 30, 2019

   · 

  5 min read
• Policy

  Urovant Sciences Announces Submission of New Drug Application for Vibegron for the Treatment of Overactive Bladder

  Urovant Sciences announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval of once-daily 75mg vibegron for the treatment of patients with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

  December 30, 2019

   · 

  4 min read
• Business

  MedMira Reports First Quarter Results FY2020

  MedMira Inc., reported on its financial results for the quarter ended October 31, 2019.

  December 30, 2019

   · 

  3 min read
• Biotech Bay

  Dr. Stanley Jacobs Unveils New Zone Lifts for Improved Facial Surgery Customization

  The San Francisco Bay Area plastic surgeon shared his temple and posterior neck lifts at a fall facelift presentation

  December 30, 2019

   · 

  2 min read
• BraineHealth - Leveraging Digital Technologies to Revolutionize Healthcare

  The Swedish company BraineHealth spearheads the evolution of eHealth by leveraging new digital technologies to make quality healthcare accessible to patients globally

  December 30, 2019

   · 

  2 min read